APOGEE THERAPEUTICS Trademark

Trademark Overview

On Tuesday, April 16, 2024, a trademark application was filed for APOGEE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the APOGEE THERAPEUTICS trademark a serial number of 98502202. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 26, 2024. This trademark is owned by Apogee Therapeutics, Inc.. The APOGEE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services of new pharmaceutical products
apogee therapeutics

General Information

Serial Number98502202
Word MarkAPOGEE THERAPEUTICS
Filing DateTuesday, April 16, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements

NOT AVAILABLE“THERAPEUTICS"
Goods and ServicesResearch and development services of new pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 16, 2024
Primary Code042
First Use Anywhere DateThursday, December 8, 2022
First Use In Commerce DateThursday, December 8, 2022

Trademark Owner History

Party NameApogee Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453
Party NameApogee Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events

Event DateEvent Description
Tuesday, April 16, 2024NEW APPLICATION ENTERED
Sunday, September 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 29, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 29, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, October 29, 2024ASSIGNED TO EXAMINER
Tuesday, October 29, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, October 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

therapeutics apogee products pharmaceutical services development research